Clinical Trial Update: Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing two initiation strategies for etoposide in severe Hemophagocytic lymphohistiocytosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 3 | Status: NOT_YET_RECRUITING